A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

Incannex Healthcare Inc. (NASDAQ:IXHL) on Thursday detailed an updated clinical development plan for IHL-42X, its oral ...

Researchers say a medication originally used for epilepsy may significantly reduce breathing interruptions in people with sleep apnea, raising the possibility of a pill-based treatment.

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

A clinical trial shows sulthiame lowers breathing interruptions in sleep apnea and improves oxygen levels, raising hope for a medication alternative to CPAP therapy.

COLUMBUS, OH - February 24, 2026 - PRESSADVANTAGE - As awareness of obstructive sleep apnea continues to grow across ...

A nerve stimulator implant called Inspire is helping some sleep apnea patients breathe normally at night when a CPAP machine is not an effective treatment.

Incannex shares drop after announcing a $10 million stock offering to fund its IHL-42X sleep apnea study following positive ...

Adequate sleep (about seven to eight hours for adults) is crucial to your health, alertness and more. Obstructive sleep apnea ...